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order to decentralise medical treatment for people living 
with HIV in the Ségou region of Mali 
P. Teisseire1, A. Akonde1, C. Pizzocolo2, S. Calmettes2, N. Bodo2, and L. Pizarro2 
1Solthis Mali, rue 189, porte 372, Koroina Nord, BP3062, Bamako, Mali 
2Solthis Paris, 58A, rue du Dessous des berges, 75013, Paris, France 
Abstract. Medical treatment for people living with HIV/AIDS started in Mali as early as 1997 thanks to 
civil society. The national response was oficialised by the adoption of the Malian Initiative for Access to 
Antiretroviral Therapy (Initiative Malienne d’Accès aux Antirétroviraux IMAARV). In 2004 ART, drugs 
against opportunistic infections and basic biological monitoring were made available free of charge by 
decree. In 2005, decentralisation of health-care to regions and circles became one of the main thrusts of the 
national strategy for the ight against the pandemic. 
Sub-Saharan African countries are making signiicant efforts to provide full geographical coverage of their 
national territory. 
It is in this “scaling-up” context that the Solthis NGO (Solidarité Thérapeutique et Initiatives contre le Sida) 
began cooperating with Malian actors to extend access to quality treatment for patients living with HIV/AIDS 
in the city and region of Ségou. Based on a developmental approach, Solthis opted for continuing in situ 
technical support for national actors in the ight against AIDS. Thanks to the daily presence of a team “in the 
ield” Solthis devotes a large part of its activities to capacity-building for health-care workers through an 
exchange of medical and scientiic expertise. 
Efforts were also made to improve health-care workers’ working conditions and to make various tests and 
drugs accessible to patients infected with HIV. 
The initial aim was to encourage universal access to ART. Today, the Ségou programme supported by Solthis 
has developed over 1,500 new treatments in the region. In addition, every PMTCT centre in the region offers 
prevention and treatment services to mothers and children. Today, the Ségou region is an integral part of the 
IMAARV initiative as a decentralisation pilot project. 
 1 Background 
1.1 Decentralisation of HIV/AIDS treatment in Africa 
Today Africa remains the continent where health-care needs 
are the most urgent. Lack of access to essential medication, 
and the need for human resources, adequate health-care infra-
structure and facilities are the obstacles to be surmounted in 
order to provide a genuine right to health for all. Unfortu-
nately, today most African rural people still suffer from very 
limited access to health-care services. 
The HIV epidemic is an unprecedented scourge in the his-
tory of mankind. Never before has a disease raised such public 
health challenges. Since its appearance in 1981, it has affected 
over 65 million people. Although prevention of opportunistic 
infections and the introduction of antiviral therapy in 1996 
have drastically changed the natural course of the disease and 
improved many patients’ life quality and expectancy, on 
the whole treatment is mainly available for people living in 
rich countries and is still cruelly lacking where it most 
urgently needed. 
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The decentralisation of HIV/AIDS treatment from capitals 
to regional areas was decided in view of this situation and 
from a will to facilitate access to adequate medical care 
(screening, diagnosis and therapy). To achieve this, the 
involvement of local authorities in coordinating the ight 
against the epidemic is essential. 
There are two approaches in the ield. Either specialized 
HIV/AIDS health centres can be created, or use can be made 
of existing health-care centres while preserving the national 
health pyramid-like structures. The two approaches are often 
applied jointly at different levels depending on the country. In 
either case, governments try to ensure full geographical 
coverage of their national territory. 
Naturally, scaling-up treatment depends on the capacity of 
States to commit funds and mobilise resources. The available 
referral systems show considerable disparities, ranging from 
full coverage of all health districts in one region to total lack 
of antiretroviral therapy (ART) in other regions of the same 
country (Mali). 
1.2 Mali: general data 
Mali is a landlocked country located in the East of West 
Africa in the Sahel-Sahara area (Fig. 1). Mali is one of the 
poorest countries in the world: according to the Human 
Development Index (HDI) developed by the United Nations 
Development Programme (UNDP) for 177 countries, Mali 
ranks 173rd (UNDP, 2008) (Table 1). Malians, of which there 
are an estimated 12 million, are unequally distributed 
throughout the country, with a relatively high density in the 
South and a very low one in the North. 
The Malian health care system is organized on the basis of 
the country’s administrative division into eight regions plus 
one district (the capital, Bamako). Each region is made up of 
several circles (or prefectures) made up in turn of several 
towns. The health-care system is therefore built like a pyra-
mid with a central level involving National Reference Hospi-
tals, an intermediate level involving Regional Reference 
Hospitals (seven in all), and the lower level made up of health 
care districts in the circles. In spite of this meshed structure, 
over half of Malian households live more than 5 km from a 
health-care centre. 
1.3 HIV/AIDS situation in Mali 
With a population of 12 million and an estimated prevalence 
of 1.3%1 in adults, the number of people infected with HIV/
AIDS in the country is estimated at 130,000 and the number 
of people needing ART at 27,000. Women have a higher 
prevalence (1.4% versus 0.9% for men) with a peak in the 
25–30 age-bracket. Urban prevalence is 1.6% versus 0.9% in 
rural areas. The city of Bamako has the highest prevalence in 
the country (1.9%). 
As to the programme for the prevention of mother to child 
transmission (PMTCT), an estimated 13,000 pregnant 
women are infected with HIV but only 3% are estimated to 
beneit today from ART for PMTCT. The number of children 
(aged 0 to 14) living with AIDS is estimated at 16,000, 
5,500 needed ART in 2006 and 600 children were estimated 
to beneit from ART at the end of 2007. 
Antiretroviral treatment for people living with HIV/AIDS 
started as early as 1997 at CESAC (Centre d’Écoute, de 
Soins, d’Animation et de Conseils) in Bamako. As a concrete 
expression of the national response, the Malian Initiative for 
Access to Antiretroviral Medication (Initiative Malienne 
d’Accès aux antiréviraux) was launched in 2001 and has ex-
panded signiicantly over the last few years, with strong po-
litical commitment towards ighting HIV. This commitment 
led to national funds being rapidly made available, to the 
public national declaration in April 2004 making AIDS a pri-
ority, and above all a decree making ART, drugs against op-
portunistic infections, and basic biological monitoring avail-
able free of charge in the Spring of 2004. 
At the institutional level, the National Programme for the 
Fight against AIDS was replaced in 2005 by the Sectorial 
Coordinating Unit for the Fight against HIV/AIDS (CCSLS) 
within the Ministry of Health. The CCSLS is now responsible 
for implementing the strategic framework. When the HIV/
AIDS sectorial plan of the Ministry of Health was drawn up 
in June 2005, the decentralisation of health-care to regions 
and circles was made a national priority. 
Numerous partners have also mobilized against HIV/AIDS 
in Mali (World Bank, Global Fund, French ODA, etc.) and 
Table 1. Socioeconomic data. 
Population  12 million
Life expectancy at birth  53 years
HDI ranking out of 177 countries  173
Infant mortality (under age 1)  120
Physicians per 100,000 inhabitants  8
Total health expenditure in GDP %  6.6%
Total health expenditure per capita (USD PPA)  US $ 54
Adult literacy rate  24%
Gross national income per capita (USD PPA)  US $ 1,033
Figure 1. Location on the map.
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 1 Demography/health survey, EDSM IV, 2006. 
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Malian civil society which initiated treatment efforts now 
plays a prime role in the health care system. 
2 The decentralisation process  
in the Ségou region 
2.1 Description of the Ségou region 
The Ségou region beneits from a central location between 
the Koulikoro, Mopti, Timbuktu and Sikasso regions. It has 
part of the borders with the Republics of Burkina Faso and 
Mauritania. Its location has given it an historical role as a 
national and international crossroad. Constituted of eight 
circles, the city of Ségou is its capital. It has an estimated 
population of 2 million, half aged under 15 and 80% living in 
rural areas. 
Ségou covers 65 000 km2, 5% of the country’s total area. The 
region is divided into 7 circles (Barouéli, Bla, Macina, Niono, 
San, Ségou and Tominian) which all have a Health 
Reference Centre (CSRef) and a central Community Health 
Centre (CSCom central)., Each circle has a varying number of 
Community Health Centres (CSCom) generally set up accord-
ing to population density and existing community facilities. 
The region has 118 municipalities encompassing 2166 villages. 
The regional health-care pyramid in Mali is constituted 
irst of the Regional Health Directorate (DRS) and of the 
Regional Hospital, both situated in the capital’s circle. The 
DRS governs all the activities of the health sector, whether 
they are funded by the Malian Government (public services 
and local or regional authorities) or by development organiza-
tions (bi-and multilateral programmes, national and 
international NGOs). For example, it monitors health-care 
workers, improves their skills, and assesses their activities 
through integrated supervisory systems. 
For any intervention in a Community Health Centre 
(CSCom), in addition to consulting those in charge (CSRef 
Head Medical Oficer and CSCom head of station, physician 
or nurse), the agreement in principle of the organization 
managing the site (ASACO) must be obtained, thus complet-
ing the local authority consultation phase. Technical and 
inancial partners must keep the authorities informed and 
consult the different actors. This minimizes potential duplica-
tion and more particularly ensures better coordination of 
available resources. 
2.2  The Solthis approach 
In 2003, the main objective of the project was to “allow 
eficient ARV treatment of patients coming to health-care 
structures. This was a pilot programme providing free drugs.” 
The indicators selected to monitor activities were: 
- A monthly enrolment of approximately 3 children 
and 23 adults. To be reviewed according to needs and 
programme capacity. 
- In monitoring centres for pregnant women involved in 
the programme, all women should have access to HIV 
screening and advice, and to ARV treatment for 
themselves or to prevent mother to child transmission. 
To help Mali decentralise treatment for people living with 
HIV, Solthis has been working along ive strategic directions: 
1. Capacity-building for local health-care workers through 
various training initiatives, 
2. Improving the capacity of laboratories in the region and 
the links between them and the capital to provide 
biological monitoring of all Ségou patients, 
3. Supporting the national and regional drug and reagent 
supply system, 
4. Developing a data collection and analysis system for all 
patients monitored in the region, and, 
5. Supporting regional and national coordination bodies 
in choosing both national protocols and health policies 
related to decentralisation. 
This went hand in hand with a strengthening of site 
resources and equipment: rehabilitation of drug distribution 
warehouses and of maternity hospitals; supply of small 
equipment. Material and speciic organizational support was 
also provided to patient support groups. 
2.3 The various decentralisation stages in the 
Ségou region 
The programme for access to ART developed and supported 
by Solthis in Ségou and included in the Malian Initiative for 
Access to ART (IMAARV) as a pilot decentralisation project is 
now fully anchored in the 2005–2009 Sectorial Plan for the 
ight against HIV/AIDS, spearheaded by the Mali Ministry of 
Health of Mali. 
After almost four years, the programme has moved on 
from the decentralisation of treatment from the capital to the 
region and is now working on scale-up within the region 
itself (Fig. 2). 
2004–2005: 
- Initial and continuous training of available human 
resources (physicians, pharmacists, laboratory techni-
cians, midwives, nurses), 
- Supply of equipment (automated CD4 counters, plasma 
banks, small laboratory appliances), 
- Rehabilitation of facilities such as laboratory rooms, a 
pharmaceutical store in the Regional Hospital and 
consultation rooms in maternity hospitals where 
prevention of mother to child transmission (PMTCT) 
activities take place. 
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2006: 
- Gradual roll-out to the whole region, 
- First, PMTCT work spread to Bla and Niono circles, 
- Next, work concentrated on extending comprehensive 
treatment to those circles and to the San circle. 
2007: 
- Support for all actors already involved in HIV/AIDS 
response through improved treatment quality, 
- Opening of two PMTCT centres in the three circles of 
the region (Macina, Markala, Baraouéli) that did not 
have any until then, 
- Creation of a Ségou/Bamako sampling circuit for viral 
load tests. 
Timing of medical treatment centre openings in the 
Ségou region: 
 - 2004: 4 ARV and OI sites in the Ségou city circle, 
 - 2005: 4 new ARV and OI sites in Ségou city, 
 - 2006: ARV and OI sites in the CSRefs of the Bla, Niono 
and San circles, 
 - 2007: ARV and OI sites in the CSRefs of the Baraouéli, 
Macina, Markala and Tominian circles. 
In all for the region, the Ségou programme for access to 
ART has allowed launching and expanding the ight against 
HIV/AIDS in: 
 - 15 comprehensive treatment sites, 
 - 10 paediatric treatment sites, 
 - 28 PMTCT sites, 
 - 17 screening sites including 7 voluntary screening 
centres. 
2.4  Description of therapeutic treatment of patients 
in Ségou 
First of all, it is important to note that Solthis focuses its tech-
nical support on medical treatment for patients. This paper 
therefore will not deal with activities relating to prevention 
and awareness-raising, or with the social and psychological 
support provided by community organizations. 
Solthis supported the creation of a single patient medical 
record for the whole region. Data collected are entered in the 
Fuchia software developed by Médecins Sans Frontières and 
Epicentre. Solthis managed the implementation of the system. 
All patients in the region receive medical treatment 
complying with international protocols, those drawn up by 
WHO in particular. Solthis contributed to an updating of 
national protocols. 
In particular: 
- 2004: Use of single dose combined D4T-3TC-NVP 
(Triomune) as irst line treatment. The second line is 
ABC-ddI-IDV/r, 
 - 2007: Switching to AZT-3TC-NVP as irst line treatment 
if possible, as recommended recently by WHO. As 
a second line, LPV/r can be proposed instead of IDV/r, 
 - 2007: Use of a tri-therapy regimen for the prevention 
of mother to child virus transmission. 
Solthis has helped women who so wish to receive breast 
milk substitutes during the irst six months. Thought is being 
given to generalize tri-therapy for nursing mothers thus al-
lowing them to avoid the social and medical drawbacks of 
substitute milk. 
In the same vein, all patients can beneit throughout from 
im mu nological follow-up (CD4) starting from pre-therapy 
tests. 
In addition, since 2007, all patients have access to a viral 
load test as of 6 months so as to ensure optimal treatment 
follow-up. In some cases, a resistance proile is determined 
in partnership with the virological laboratory of the 
Pitié-Salpêtrière hospital in Paris. 
As to Opportunistic Infections (OI), until the Malian 
Government took over, Solthis subsidised the anti-OI drugs 
which were not yet available to patients. Naturally, all pa-
tients receive Cotrimoxazole as a prophylactic. 
2.5 Resources mobilized for the project 
Solthis intervenes at three different levels in its projects. 
The irst level involves ield teams. In Mali, the team is 
headed by a project oficer and has a medical coordinator, 
(a physician specialised in HIV/AIDS), a medical assistant 
(a supporting physician for decentralisation to the districts) 
a person in charge of mother/child issues (a supporting 
midwife for PMTCT sites), a data entry operator (for data 
collection and analysis), and an administrative and inancial 
oficer. The team provides continuous technical support to 
local actors involved in care. 
Figure 2. Chronology of decentralisation in the Ségou region. 
Total number of sites at end of 2007:  
– 28 PMTCT centres  
– 15 Medical treatment centres 
 2004
Ségou
Niono
San
BlaBaraoueli 
Macina 
Tominia
 2005
Ségou
Niono
San
BlaBaraoueli
Macina
Tominia
 2006
Ségou
Niono
San
BlaBaraoueli 
Macina 
Tominia
 2007
Ségou
Niono
San
BlaBaraoueli
Macina
Tominia
Operational comprehensive 
treatment sites  
Site benefiting from PMTCT 
training 
Operational PMTCT site  
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The second level calls on all the voluntary scientiic teams 
that are members of Solthis. For this project, this involves in 
particular the clinical team headed by Professor Christine 
Katlama, the virology team headed by Professor Vincent 
Calvez, and the immunology team headed by Professors Pa-
trice Debré and Brigitte Autran. The three teams are based in 
the Pitié-Salpˆetrière Hospital in Paris. A fourth team, headed 
by Dr Arnaud Fontanet (Department for the epidemiology of 
emerging diseases) at the Pasteur Institute in Paris, provides 
essential support in programme assessment and follow-up. 
All the teams support the project with in situ missions (train-
ing, workshops, scientiic conferences, etc.) and distance 
technical assistance. 
The last level involves the Solthis coordination team 
based in Paris. It monitors the project and provides an 
interface between ield technical support and members’ 
scientiic expertise. 
The budget deined for the project was 2 million euros over 
5 years and was funded thanks to the support of the 
Bettencourt-Schueller Foundation. The main item of expen-
diture (40%).is related to the human resources involved in 
continuous technical support. The two other most expensive 
items are investment in pharmaceuticals and in training. 
3 Results of decentralised medical treatment for  
 HIV/AIDS in Ségou 
3.1 Local capacity-building 
Solthis, in view of its members’ experience and expertise, has 
chosen to concentrate capacity-building in ive main areas: 
health-care providers (physicians and paramedics2); labora-
tory staff; staff involved in the pharmaceutical supply chain; 
staff responsible for data collection and analysis; staff in 
charge of HIV/AIDS-related health policies. 
At the start of the Ségou programme for access to ART, none 
of the medical staff had been speciically trained in HIV/AIDS 
treatment. Four years later, as a result of the support pro-
gramme for decentralisation, a total of 250 health-care 
workers have been trained in the Ségou region. 
In all, 67 physicians have beneited from initial training 
followed by retraining and continuing medical support pro-
vided by the Solthis team. In total, 57 of them were able to 
acquire speciic skills in clinical and therapeutic management 
(ART and diagnosis of OIs), 10 in paediatric HIV treatment, 
16 in PMTCT medical support, and 7 in the treatment of the 
TB/HIV coinfection; 17 physicians not directly involved in 
the treatment of infected patients beneited from an HIV/
AIDS awareness programme in order to improve early screen-
ing and treatment for those patients. 
Paramedical staff (168 people in all) were also given 
speciic training and continuing technical support in several 
areas. This involved 91 maternity hospital workers (PMTCT), 
15 nurses in nursing care for patients, 17 laboratory techni-
cians (improvement of IO diagnosis), and 16 other people in-
volved in drug supply chain management, drug dispensing and 
supplies. In addition, 41 paramedics (midwives, nurses, social 
workers) were trained in therapeutic education, 21 of them in 
comprehensive treatment sites and 17 in PMTCT sites. 
Since its onset, the programme has also facilitated partici-
pation in nine further training courses at the Pitié Salpêtrière 
Hospital in France (seven physicians and two biologists), 
and in seven international university training courses 
(IMEA course in Paris and DIU in HIV/AIDS treatment 
in Ouagadougou). 
3.2 Capacity-building specificities 
Training modules were developed and taught in partnership 
with national experts (academics, experienced physicians 
and pharmacists). 
Regular support for actors in their work-place is also essen-
tial in order to ensure that theoretical training is adapted to 
their actual work situation since it is not always conducive to a 
comprehensive view of patient management in a multidisci-
plinary health-care team. This is very important in terms of 
organizing an eficient patient referral system within a particu-
lar structure or between different sites. It also allows complex 
treatment cases to be discussed eficiently in staff meetings. 
Laboratory and pharmaceutical staff training is in line 
with the speciicities of the health pyramid since technical 
requirements at central level are greater than those of more 
remote centers. Similarly, qualiications for people in charge 
of the corresponding duties are different the further from the 
city of Ségou they are. Training dispensed by Solthis is there-
fore adapted to those speciicities with an attempt to make 
HIV-speciic tests accessible (screening tests, CD4 lympho-
cyte counts and viral load measurement) by improving the 
implementation of standard biological tests (haematology, 
biochemistry, bacteriology and parasitology). Solthis hired 
a biologist for one year to provide this kind of continuous 
technical support in the region for all the staff concerned. 
Finally, regarding data collection and follow-up, the Solthis 
Medical Coordinator and his team helped the Regional Health 
Directorate units to include these activities in their standard 
work package. Initially, Solthis hired and trained the data 
entry operator. His transfer to the RHD is planned shortly. 
3.3 Impact of support on patient health 
An analysis of the epidemiological course in the active group 
of the Ségou region shows a constant increase in enrolment 
since the start of the programme (Fig. 3). 
From January 1st 2004 to end December 2007, 1,568 pa-
tients in all had begun ART in the Ségou region. Of these 
1,568 patients, 982 are currently followed up with ART, 
165 have died and 358 have dropped out (patients who did 
not return for medical consultation). 50 were transferred to 
another prescribing site and 13 discontinued treatment. 
 2 Nurses, obstetric nurses, midwives, traditional village midwives, 
medical assistants, laboratory technical staff, medication managers, 
social workers. 
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Patients’ main features at start of treatment: 
 - Sex ratio (M/F) = 0.6 
 - Median age = 34 [IQR: 28-41] 
 - Body mass index = 18.4 [IQR: 16.4-20.7] 
 - WHO stage III = 59% and stage IV = 27% 
In most cases, 85%, irst line treatment was D4T-3TCNVP. 
Only 3% were administered a treatment based on pro-tease 
inhibitors (PI). 
Of the patients who died, 80–90% were screened belatedly 
and were therefore prescribed ART at a late infection 
phase, stages III and IV of the WHO classiication (WHO, 
2006, 2007). These patients also suffered from severe 
immunodeiciency (CD4<200 cells/mm3) and numerous 
opportunistic infections, including tuberculosis which is the 
primary cause of mortality in developing countries. 
 In 2007, a system to improve available information on 
drop-out patients was created. Its aim was to determine the 
extent of the problem so as to try and prevent it effectively. An 
analytical approach of the active group information system 
using the Fuchia follow-up software was carried out and an 
active search system for drop-outs was developed. This high-
lighted the extent of patient mobility as a cause of dropout. 
Initial clinical data for patients under ART conirm the 
signiicant effects of the HIV infection with a clear domi-
nance of the general signs typical of WHO stage III and of the 
cachectic syndrome (WHO stage IV). Minor skin and muco-
sal symptoms, localized and visceral candidiasis as well as 
bacterial and tubercular pulmonary infections were also 
found. Over the years, improvements in technical capacities 
have inluenced the diagnosis of opportunistic infections 
(OI). Patients beneit from an increasingly precise diagnosis, 
for instance regarding meningeal cryptococcosis, oesopha-
geal candidiasis or cryptosporidiosis/isosporidiosis. 
Special emphasis was placed on TB/HIV coinfection. First, 
Solthis brought together the two national ield programmes. 
Next, training was dispensed to improve TB diagnosis, treat-
ment and follow-up for people with HIV (particularly extra 
pulmonary TB). Finally, the procedure for, and organization 
of follow-up for patients under treatment for TB and/or ART 
was clariied. Today HIV screening is proposed systemati-
cally to TB carriers and HIV patients are actively screened 
for TB (smear-negative pulmonary TB or extra pulmonary 
TB), thanks to the presence of advisers. 
The improvement in technical facilities is of special inter-
est for immunological and virological follow-up of seroposi-
tive patients under ART. Severe immunodeiciency (median 
CD4 112/mm3) is observed on enrolment in most of these 
patients. A noticeable clinical improvement and a signiicant 
immune response were observed in patients assessed 
6 months after onset of treatment: the median CD4 gain in 
patients under ART was +133 cells/mm3. An initial analysis 
of the viral load is very encouraging since it shows a non-
detectability rate of over 74%, a result which is comparable 
to those of cohorts in countries of the North. 
Thanks to data collected from midwives’ registers (consul-
tations and deliveries) and the Fuchia data base, it was pos-
sible to carry out an initial evaluation of the results of the 
PMTCT programme from December 2004 to December 2007 
for mothers found to be HIV-positive and their children. Pre-
liminary results 36 months after PMTCT programmes were 
introduced show a high rate of screening acceptance: out of 
43,269 new antenatal consultations, HIV screening was pro-
posed to 77% of pregnant women with an acceptance rate of 
over 92%. 536 HIV-positive cases were found, i.e. 1.73% of 
the women screened. Since 2007 almost all HIV-positive 
pregnant women are put under a tri-therapy regimen and 
children can beneit from an early diagnosis using the PCR 
technique carried out in Bamako. 
In a study carried out from January 2006 to March 2008 
involving 8 PMTCT sites in the Ségou region, 436 women 
were found to be HIV-positive. In March 2008, 252 of them 
had given birth (245 live babies). Treatment had been admin-
istered to 144 women, 46 receiving tri-therapy. Incomplete 
treatment had been administered to 10% and none to 19%. At 
the end of the study, 48 children were still being followed up 
and 44 of them had a negative PCR diagnosis. Median age for 
diagnosis was 106 days. All the children were symptom-free 
and were receiving cotrimoxazole. Breast milk substitute was 
used by 56% of women and 27% nursed while under tri- 
therapy. The high percentage of female drop-outs after 
screening or delivery as well as the low follow-up rate for 
children after delivery underline the need for increased 
efforts in comprehensive care for HIV-positive women and 
their children. 
4 Discussion: main obstacles encountered four  
 years on 
The main objective of the project has been reached after four 
years with over 1,500 patients initiating antiretroviral treat-
ment. In addition, almost all PMTCT sites have the necessary 
tools to screen and follow up HIV-positive pregnant women 
and their children. 
Figure 3. Epidemiological evolution of the active group in Ségou, 
January 2004–December 2007.  
- Initiation ARV = Start of ART  
- Suivi sous ARV = ART follow-up  
- Perdus de vue = Lost to follow-up  
- Décédés = Deaths 
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In spite of such fundamental progress, dificulties persist. 
With various public information campaigns, Solthis has 
contributed to raise awareness of the existence of eficient 
HIV treatment in the Ségou region. These initiatives have led 
to an increase in the number of screenings and therefore to 
improved antiretroviral coverage. However, people living with 
AIDS are still severely stigmatized, especially in rural areas, 
and this has an impact on the quality of care as demonstrated 
by the low percentage of HIV-positive pregnant women re-
ceiving full treatment. 
Solthis does not provide psychological and social support 
to patients. Some national NGOs have specialised in this kind 
of work for AIDS patients and now provide services (compli-
ance, food aid, etc.) which are more effective than those 
available in public structures. The public health system needs 
to address this challenge. Synergies within health-care teams 
and with NGOs should be sought so as to be able to provide 
comprehensive quality care to all patients. Solthis may have 
to consider speciic activities along those lines. 
Overall indicators for medical follow-up of patients (num-
ber of patients under treatment, number of deaths and 
dropouts) are comparable to those of other countries in the 
region (Toure et al., 2008; ART-LINC, 2008). The main char-
acteristic of these cohorts is the high number of early deaths 
among people screened late (Stringer et al., 2006). However, 
these results should be compared to those obtained by public 
health structures in a “real life” environment and not to close-
ly controlled cohorts (Palombi et al., 2007). 
Conversely, scaling up in a country like Mali should not be 
compared to what happens in Southern or Eastern African 
countries which have a high prevalence of the epidemic. Most 
of them also experience considerable human resources prob-
lems (Jahn et al., 2008; Van Damme et al., 2008). The main 
obstacles in the case of Mali are distance and inadequate health 
infrastructures. With a seroprevalence of 1 to 2%, decentralis-
ing HIV/AIDS treatment services should be carried out in the 
context of an overall improvement in health-care supply for 
the population at large. An HIV-speciic vertical plan would be 
dificult to understand for health-care workers and people 
faced with other severe pathologies. 
Issues such as “task shifting” are relevant in that context 
when it involves allowing pregnant women to beneit from 
comprehensive care within a single antenatal structure, 
thanks to midwife-prescribed tri-therapy, without having to 
travel dozens of miles to visit a prescribing centre with a 
physician in attendance. 
Regarding patient care, there is at present considerable 
heterogeneity between centres. It is manifest between Ségou 
city and the districts, and also between districts and between 
care structures within Ségou city itself. It is due to various 
aspects relating to both the inadequacy of the regional health 
system and health-care team motivation. Medical technical 
support as provided by Solthis can only offer a very partial 
answer to these kinds of dificulties. 
Mention should also be made of dificulties linked to the 
supply of pharmaceuticals. Although the regional system is 
making optimal progress, it remains dependent on various dis-
ruptions and anomalies at central level. Mali beneits from aid 
provided by two of the major international donors (the Global 
Fund and the World Bank), but drug shortages are still com-
mon, in particular because of poor management of quantities 
and orders. Solthis experienced dificulties in intervening at 
central level and therefore did not have a major impact. 
In addition, the oficial decision in 2004 to make care free of 
charge applies mainly today to ARV drugs. Solthis has there-
fore decided to contribute inancially to a large number of 
supplementary tests and anti-OI drugs. Sustainability remains 
a challenge. 
Another weak point relates to data collection and monitor-
ing. The irst dificulty observed, indeed the most serious one, 
is the fact that record-keeping by staff is haphazard. There is 
no culture of “patient records” as a standard practice and 
including the tool in a decentralisation project raises dificul-
ties. Of course, staff must be involved in the establishment of 
records, and documents need to be simpliied as much as pos-
sible and must present a genuine advantage for daily medical 
practice. Unfortunately, the project has only partly achieved 
this aim. 
On this aspect, it was dificult not to take the place of 
nationals to access quality data indicating the advancement of 
the programme. Also, making physicians aware of the issues 
related to the assessment of their cohort and operational 
research proved dificult. This is particularly evident for 
those with long years of practice behind them and entrenched 
habits. Maybe the new generations of physicians will prove 
to be the solution to the problem. 
The Mali programme was the irst one to be implemented 
by Solthis and logically, Solthis adjusted its operating 
methods over the four years. This was made possible to a 
large extent thanks to the lexibility of the main donor (the 
Bettencourt-Schuller Foundation) who allowed Solthis to 
adapt continually in response to the changing context and the 
analysis of the results obtained. The main changes in the 
Solthis approach concern its position in relation to the 
various Malian health system public structures. The technical 
support provided by Solthis initially focused on health-care 
centres and their staff. It was gradually extended to the Ségou 
Regional Health Directorate which is the real care supply 
coordinator. Less regularly but just as importantly, support 
was also extended to national technical authorities. This 
aimed essentially at allowing local and national levels to gain 
ownership of decentralisation mechanisms. 
5 Conclusions 
Organising the ight against HIV/AIDS raises new issues in 
terms of humanitarian medical assistance and development 
aid. The objective for Solthis is to provide technical support 
to Malian health-care workers in the Ségou area, not to care 
itself for HIV-infected patients. 
It is a bold challenge which involves a degree of risk. 
Capacity-building for local personnel is part of a process 
which necessarily takes time. Introducing new laboratory 
techniques is not easy, the supply chain is complex and its 
eficient working depends on numerous factors. We also have 
to learn to work with medical data that are not always avail-
able – and when they are, are often of poor quality. Ultimate-
ly, although there is political will and commitment, the 
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national authorities do not always have the resources needed 
to cope with the seriousness of the epidemic. 
However, in spite of all the constraints, we can conclude 
that the strategy chosen by Solthis has proved effective. Not 
only has the initial objective (number of patients in care) 
been reached, but the health-care system in the Ségou region 
now seems to be in a position to include HIV care in its daily 
operations. 
We hope these results will have an impact on future 
de-centralisation exercises. Above all, we hope development 
actors working in the HIV/AIDS ield will redouble their 
efforts to strengthen health systems in Africa, the only solu-
tion for quality HIV care to be universally accessible. For 
Solthis, working by the side of African actors today means 
highlighting the huge challenge in terms of long–term quality 
care, and having faith in the excellence of African scientiic 
and academic standards. 
AIDS is many-facetted, its reality is always complex, but 
patients expect only one response: guaranteed and lasting 
quality access to care so as to live with HIV as long as 
possible, as well as possible, wherever they live. 
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Solthis apporte son assistance technique aux professionnels  
de santé afin de décentraliser le traitement médical des patients 
VIH dans la région de Ségou au Mali
P. Teisseire1, A. Akonde1, C. Pizzocolo2, S. Calmettes2, N. Bodo2, et L. Pizarro2 
1Solthis Mali, rue 189, porte 372, Koroina Nord, BP3062, Bamako, Mali 
2Solthis Paris, 58A, rue du Dessous des berges, 75013, Paris, France 
Résumé. Le traitement médical des malades atteints du VIH/SIDA a débuté au Mali dès 1997 grâce à la 
société civile. La réponse nationale a été oficialisée avec l’adoption de l’Initiative Malienne d’Accès aux 
Antirétroviraux IMAARV. En 2004, la disponibilité gratuite des antirétroviraux, médicaments contre les 
infections opportunistes, et des analyses biologiques de base, a été instaurée par décret. En 2005, la décen-
tralisation des soins de santé aux régions et aux petites communautés est devenue l’un des grands axes de la 
stratégie nationale de lutte contre la pandémie. 
Les pays de l’Afrique sub-saharienne font des efforts considérables pour assurer la couverture de l’ensemble 
de leur territoire. 
C’est dans ce contexte d’amélioration que l’ONG Solthis (Solidarité Thérapeutique et Initiatives contre le 
Sida) a commencé à coopérer avec les acteurs maliens ain d’étendre l’accès au traitement de qualité des 
patients atteints du VIH/SIDA dans la ville de Ségou et sa région. S’appuyant sur une approche de développe-
ment, Solthis a décidé de continuer à apporter son assistance technique sur place aux acteurs nationaux dans 
la lutte contre le SIDA. Grâce à la présence quotidienne d’une équipe « sur le terrain », Solthis consacre une 
grande partie de ses activités à développer les compétences des professionnels de santé via un échange 
d’expertise médicale et scientiique. 
Des efforts ont également été entrepris pour améliorer les conditions de travail des professionnels de santé et 
pour rendre divers tests et médicaments accessibles aux patients atteints du VIH. 
Le but initial était d’encourager l’accès universel aux antirétroviraux. Aujourd’hui, le programme Ségou soutenu 
par Solthis a permis d’élaborer plus de 1500 nouveaux traitements dans la région. En outre, chaque centre 
PMTCT de la région propose des services de prévention et de traitement pour la mère et l’enfant. La région de 
Ségou fait désormais pleinement partie de l’initiative IMAARV en tant que projet pilote de décentralisation.
Référence. Teisseire, P., Akonde, A., Pizzocolo, C., Calmettes, S., Bodo, N., and Pizarro, L.: Technical 
support by Solthis for health-care workers in order to decentralise medical treatment for people living with 
HIV in the Ségou region of Mali, Field Actions Science Report. 
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Apoyo técnico de Solthis al personal sanitario para 
descentralizar el tratamiento médico para las personas  
con VIH en la región de Ségou en Malí
P. Teisseire1, A. Akonde1, C. Pizzocolo2, S. Calmettes2, N. Bodo2, y L. Pizarro2 
1Solthis Mali, rue 189, porte 372, Koroina Nord, BP3062, Bamako, Mali 
2Solthis Paris, 58A, rue du Dessous des berges, 75013, Paris, France 
Resumen. El comienzo del tratamiento médico para las personas con VIH/ SIDA en Malí se remonta a 1997 
gracias a la sociedad civil. La respuesta nacional se oicializó con la adopción de la Iniciativa Malí para el 
Acceso a las Terapias Antirretrovirales. En 2004 se decretó por ley el acceso gratuito a la terapia antirretroviral, 
los fármacos contra las infecciones oportunistas y el control biológico básico. En 2005 la descentralización de 
la atención sanitaria para acceder a las diferentes regiones y grupos supuso uno de los principales impulsos de 
la estrategia nacional para luchar contra la pandemia.
Los países del África subsahariana están realizando importantes esfuerzos para lograr la cobertura general de 
todo su territorio nacional.
Es en este contexto de generalización donde la ONG Solthis comenzó a cooperar con actores malíes para 
extender el acceso a un tratamiento de calidad para pacientes con VIH/SIDA en la ciudad y la región de Ségou. 
Con el in de fomentar el desarrollo, Solthis optó por continuar proporcionando in situ apoyo técnico a los 
actores nacionales en la lucha contra el SIDA. Gracias a la presencia diaria «en el terreno» de un equipo, Solthis 
dedica gran parte de sus actividades al desarrollo de capacidades del personal sanitario mediante el intercambio 
de conocimientos y experiencias cientíico-médicas.
También se intentó mejorar las condiciones de trabajo del personal sanitario y proporcionar acceso de los 
pacientes con VIH a diversas pruebas y medicamentos.
El objetivo inicial era fomentar el acceso universal a las ARV. Actualmente el programa de Ségou inanciado 
por Solthis ha desarrollado más de 1500 nuevos tratamientos en la región. Además, todos los centros especializa-
dos ofrecen servicios de prevención y tratamiento a las madres y a sus hijos. La región de Ségou constituye 
actualmente una parte esencial de la iniciativa IMAARV como proyecto piloto de descentralización.
Referencia. Teisseire, P., Akonde, A., Pizzocolo, C., Calmettes, S., Bodo, N., and Pizarro, L.: Technical 
support by Solthis for health-care workers in order to decentralise medical treatment for people living with 
HIV in the Ségou region of Mali, Field Actions Science Report. 
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